Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Concert Pharmaceuticals Inc. buy klostergang

Concert Pharmaceuticals Inc.
Start price
€14.68
07.04.17 / 50%
Target price
€22.55
09.10.17
Performance (%)
-5.90%
End price
€13.81
09.10.17
Summary
This prediction ended on 09.10.17 with a price of €13.81. With a performance of -5.90%, the BUY prediction for Concert Pharmaceuticals Inc. by klostergang closed slightly in the red. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Concert Pharmaceuticals Inc. - - - -
iShares Core DAX® -0.046% 5.960% 7.403% 65.851%
iShares Nasdaq 100 0.922% 3.693% 28.138% 93.298%
iShares Nikkei 225® 3.014% 6.638% 48.886% 89.079%
iShares S&P 500 -0.359% 2.747% 22.530% 71.942%

Comments by klostergang for this prediction

In the thread Concert Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -5.90%
Target price 22.550
Change
Ends at 09.10.17

Concert has several big name partners and several "shots on goal" in its pipeline


Stifel Nicolaus and Aegis Capital reiterated Buy ratings on this small
cap "Tier 4" biotech stock yesterday (05.04.2017) with price targets of $31 and $25


klostergang 
0
Report Share
07.04.17
Prediction Buy
Perf. (%) -5.90%
Target price 22.550
Change
Ends at 09.10.17

(Laufzeit überschritten)

klostergang 
0
Report Share
09.10.17